|
|
||||||||




* Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545;
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037;
Pediatric Hematology/Oncology, School of Medicine, University of California, Los Angeles, CA 90095; and
Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390
To date, much of our knowledge about the signaling networks involved in the innate immune response has come from studies using nonphysiologic model systems rather than actual immune cells. In this study, we used a dual-tagging proteomic strategy to identify the components of the MyD88 signalosome in murine macrophages stimulated with lipid A. This systems approach revealed 16 potential MyD88-interacting partners, one of which, flightless I homolog (Fliih) was verified to interact with MyD88 and was further characterized as a negative regulator of the TLR4-MyD88 pathway. Conversely, a reduction in endogenous Fliih by small-interfering RNA enhanced the activation of NF-
B, as well as cytokine production by LPS. Results from immunoprecipitation and a two-hybrid assay further indicated that Fliih directly interfered with the formation of the TLR4-MyD88 signaling complex. These results in turn suggest a new basis for the regulation of the TLR pathway by Fliih.
This article has been cited by other articles:
![]() |
J. Li, H. L. Yin, and J. Yuan Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity J. Cell Biol., April 16, 2008; 181(2): 321 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tang, D. Metzger, S. Leeman, and S. Amar LPS-induced TNF-{alpha} factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways PNAS, September 12, 2006; 103(37): 13777 - 13782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Miggin and L. A. J. O'Neill New insights into the regulation of TLR signaling J. Leukoc. Biol., August 1, 2006; 80(2): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |